RNAZ
TRANSCODE THERA (RNAZ)
NASDAQ
$1.71+$0.05 (+3.01%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $28.1M
    Market Cap
  • -86.65%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
KEPOS CAPITAL LP
25.98%
275,000
-25,000 (-9.09%)
Mar 31, 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP
1.97%
20,854
+20,854 (+100.00%)
Dec 31, 2022
YORKVILLE ADVISORS GLOBAL, LP
1.86%
19,639
+19,639 (+100.00%)
Jun 30, 2026
VANGUARD CAPITAL MANAGEMENT LLC
0.62%
6,545
0 (0.00%)
Jun 30, 2026
N/A
0.62%
6,545
+6,545 (+100.00%)
Mar 31, 2026
ACT CAPITAL MANAGEMENT, LLC
0.61%
6,500
0 (0.00%)
Sep 30, 2022
VANGUARD FIDUCIARY TRUST CO
0.28%
2,982
0 (0.00%)
Jun 30, 2026

Current Ownership Distribution

  • Insiders12.7M (47.49%)
  • Institutions10.2M (38.01%)
  • Mutual Funds3.9M (14.50%)
  • Other0 (0.00%)

Insider Transactions

  • 47.49% (12.7M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Fitzgerald Thomas A
Chief Financial Officer
Award
Sep 09, 2026
$0.00
185,000
$0.00
185,000